Who Supplies Antitoxin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Antitoxin exports, with 45+ registered manufacturers shipping to buyers across 80+ countries — yet a handful of companies dominate the shipments. VINS BIOPRODUCTS LIMITED holds the largest share at 17.5% (export value: $2.3M). Close behind, BIOLOGICAL E. LIMITED (5.9%, $793.4K). PREMIUM SERUMS AND VACCINES PRIVATE LIMITED (5.7%, $757.9K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Antitoxin? Top Manufacturers & Their Buyers
Flow of Antitoxin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Antitoxin Supplier Network — Key Market Intelligence
The Antitoxin export market from India is led by VINS BIOPRODUCTS LIMITED, which alone commands a 17.5% share, shipping $2.3M worth of product across 206 shipments. The second-largest exporter, BIOLOGICAL E. LIMITED, contributes $793.4K (5.9%) to the overall market. Combined, the top two suppliers alone account for 23.5% of all Antitoxin exports, indicating a relatively concentrated supply base.
Across all 45 tracked manufacturers, the total Antitoxin export value stands at $13.3M from 524 shipments. The market average shipment value is $25.5K. The single largest buyer relationship in terms of trade value is CUST ID :- CMN IPDM, receiving $654.1K worth of product.
The combined buyer network spans 26 named purchasing companies, including CUST ID :- CMN IPDM, CUST ID:FPPGQ, CUST ID:IPSPN, PLANET PHARMA, CUST ID: SFSMN and 21 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1VINS BIOPRODUCTS LIMITED
VINS BIOPRODUCTS LIMITED is the first-largest Antitoxin exporter from India, with a market share of 17.5% and a total export value of $2.3M across 206 shipments. Their average shipment value of $11.3K is below the market average of $25.5K, reflecting a high-volume, competitive pricing strategy.
VINS BIOPRODUCTS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• CUST ID :- CMN IPDM — $654.1K across 58 shipments (28.0% of this supplier's total exports)
• CUST ID:FPPGQ — $540.2K across 48 shipments (23.1% of this supplier's total exports)
• CUST ID:IPSPN — $403.8K across 36 shipments (17.3% of this supplier's total exports)
• PLANET PHARMA — $377.6K across 33 shipments (16.2% of this supplier's total exports)
• CUST ID: SFSMN — $361.4K across 32 shipments (15.5% of this supplier's total exports)
Key Insight: VINS BIOPRODUCTS LIMITED operates with high shipment frequency (206 shipments) at a per-shipment value of $11.3K, indicating a broad distribution network with many smaller, regular orders.
2BIOLOGICAL E. LIMITED
BIOLOGICAL E. LIMITED is the second-largest Antitoxin exporter from India, with a market share of 5.9% and a total export value of $793.4K across 20 shipments. Their average shipment value of $39.7K is above the market average of $25.5K, suggesting premium or bulk contract pricing.
BIOLOGICAL E. LIMITED serves 5 named buyers in our database. WORLD HEALTH ORGANIZATION WAREHOUSE is the dominant customer, accounting for 51.3% of this supplier's tracked business. Top customers include:
• WORLD HEALTH ORGANIZATION WAREHOUSE — $406.7K across 10 shipments (51.3% of this supplier's total exports)
• MSF LOG-BDX SITE MERIGNAC, — $350.3K across 9 shipments (44.2% of this supplier's total exports)
• MSF LOG-BDX SITE MERIGNAC, — $26.2K across 1 shipments (3.3% of this supplier's total exports)
• GITTOES PHARMACEUTIC — $5.6K across 0 shipments (0.7% of this supplier's total exports)
• WEHEHLIYE PHARMACEUT — $4.5K across 0 shipments (0.6% of this supplier's total exports)
Key Insight: BIOLOGICAL E. LIMITED's per-shipment value of $39.7K is 56% above the market average of $25.5K, consistent with large-order contracts or value-added formulations.
3PREMIUM SERUMS AND VACCINES PRIVATE LIMITED
PREMIUM SERUMS AND VACCINES PRIVATE LIMITED is the third-largest Antitoxin exporter from India, with a market share of 5.7% and a total export value of $757.9K across 71 shipments. Their average shipment value of $10.7K is below the market average of $25.5K, reflecting a high-volume, competitive pricing strategy.
PREMIUM SERUMS AND VACCINES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• WORLD HEALTH ORGANIZATION WAREHOUSE — $342.8K across 32 shipments (45.2% of this supplier's total exports)
• MEDECINS SANS FRONTIERES LOGISTIQUE — $165.8K across 16 shipments (21.9% of this supplier's total exports)
• STRAIT AIR TRANSPORT — $135.7K across 13 shipments (17.9% of this supplier's total exports)
• UNICEF PAKISTAN COUN — $64.6K across 6 shipments (8.5% of this supplier's total exports)
• CENTRE POUR LE DEVEL — $48.8K across 5 shipments (6.4% of this supplier's total exports)
Key Insight: PREMIUM SERUMS AND VACCINES PRIVATE LIMITED operates with high shipment frequency (71 shipments) at a per-shipment value of $10.7K, indicating a broad distribution network with many smaller, regular orders.
4SERUM INSTITUTE OF INDIA PRIVATE LIMITED
SERUM INSTITUTE OF INDIA PRIVATE LIMITED is the fourth-largest Antitoxin exporter from India, with a market share of 3.1% and a total export value of $418.4K across 62 shipments. Their average shipment value of $6.7K is below the market average of $25.5K, reflecting a high-volume, competitive pricing strategy.
SERUM INSTITUTE OF INDIA PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• M & G PHARMACEUTICAL — $104.0K across 15 shipments (24.9% of this supplier's total exports)
• DUOPHARM AGENCE CENT — $95.1K across 14 shipments (22.7% of this supplier's total exports)
• LUCKY DEVELOPMENT CO — $82.5K across 12 shipments (19.7% of this supplier's total exports)
• APROMED PHARMA — $77.5K across 11 shipments (18.5% of this supplier's total exports)
• DUOPHARM AGENCE CENT — $59.3K across 9 shipments (14.2% of this supplier's total exports)
Key Insight: SERUM INSTITUTE OF INDIA PRIVATE LIMITED operates with high shipment frequency (62 shipments) at a per-shipment value of $6.7K, indicating a broad distribution network with many smaller, regular orders.
5VINS BIOPRODUCTS LTD
VINS BIOPRODUCTS LTD is the fifth-largest Antitoxin exporter from India, with a market share of 2.8% and a total export value of $370.0K across 19 shipments. Their average shipment value of $19.5K is below the market average of $25.5K, reflecting a high-volume, competitive pricing strategy.
VINS BIOPRODUCTS LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• CUS ID UPMES URKPHAR — $129.6K across 7 shipments (35.0% of this supplier's total exports)
• INSTITUT PASTEUR DU — $85.2K across 4 shipments (23.0% of this supplier's total exports)
• CUST ID FPPGQ PLANET PHARMA ZAC DU GRAND — $66.0K across 3 shipments (17.9% of this supplier's total exports)
• CUST ID IFBTP PT BIO — $48.3K across 2 shipments (13.0% of this supplier's total exports)
• CUST ID MLDPI INSTIT — $40.8K across 2 shipments (11.0% of this supplier's total exports)
Key Insight: VINS BIOPRODUCTS LTD operates with high shipment frequency (19 shipments) at a per-shipment value of $19.5K, indicating a broad distribution network with many smaller, regular orders.
6BIOLOGICAL E LIMITED
BIOLOGICAL E LIMITED is the fifth-largest Antitoxin exporter from India, with a market share of 2.2% and a total export value of $293.2K across 6 shipments. Their average shipment value of $48.9K is above the market average of $25.5K, suggesting premium or bulk contract pricing.
BIOLOGICAL E LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• CENTRALE D ACHAT DES — $130.6K across 3 shipments (44.6% of this supplier's total exports)
• NCDC (NIGERIA CENTRE — $75.0K across 2 shipments (25.6% of this supplier's total exports)
• NCDC (NIGERIA CENTRE — $75.0K across 2 shipments (25.6% of this supplier's total exports)
• SALAMA — $12.6K across 0 shipments (4.3% of this supplier's total exports)
• NFPHARMA OOO — $0 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: BIOLOGICAL E LIMITED's per-shipment value of $48.9K is 92% above the market average of $25.5K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Antitoxin Flows
Once Antitoxin leaves the manufacturing plants of companies like VINS BIOPRODUCTS LIMITED and BIOLOGICAL E. LIMITED, it travels to 5 destination markets with a combined import value of $13.3M. France absorbs the largest share at 30.9% ($4.1M), followed by Morocco (11.4%) and United Arab Emirates (7.5%).
In France — the top destination — named importers include FPPGQ, CUST ID:FPPGQ, MEDECINS SANS FRONTIERES LOGISTIQUE. In Morocco, key buyers are CUST ID :- CMN IPDM 002, CUST ID:MLDPI, CUST ID :- CMN IPDM 001.
This geographic spread reflects Antitoxin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Antitoxin Go? Top Importing Countries & Their Buyers
Trade flow of Antitoxin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1France
France ranks as the first-largest destination for Antitoxin imports from India, with a total trade value of $4.1M across 69 shipments — representing a 30.9% share of all Antitoxin exports. The average shipment value of $59.7K is above the global average of $25.5K, indicating high-value procurement contracts or branded formulations. This market is served by 9 tracked buyers.
Named Antitoxin importers in France: FPPGQ is the largest buyer, accounting for 16.0% ($658.3K) of this market's total imports.
• FPPGQ — $658.3K (16.0% of France's total)
• CUST ID:FPPGQ — $540.2K (13.1% of France's total)
• MEDECINS SANS FRONTIERES LOGISTIQUE — $415.1K (10.1% of France's total)
Key Insight: France's per-shipment average of $59.7K (134% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
France is a key market for Antitoxin imports from India.
2Morocco
Morocco ranks as the second-largest destination for Antitoxin imports from India, with a total trade value of $1.5M across 9 shipments — representing a 11.4% share of all Antitoxin exports. The average shipment value of $168.3K is above the global average of $25.5K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Antitoxin importers in Morocco: CUST ID :- CMN IPDM 002 is the largest buyer, accounting for 43.2% ($654.1K) of this market's total imports.
• CUST ID :- CMN IPDM 002 — $654.1K (43.2% of Morocco's total)
• CUST ID:MLDPI — $216.2K (14.3% of Morocco's total)
• CUST ID :- CMN IPDM 001 — $214.6K (14.2% of Morocco's total)
Key Insight: Morocco's per-shipment average of $168.3K (561% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Morocco is a key market for Antitoxin imports from India.
3United Arab Emirates
United Arab Emirates ranks as the third-largest destination for Antitoxin imports from India, with a total trade value of $997.7K across 10 shipments — representing a 7.5% share of all Antitoxin exports. The average shipment value of $99.8K is above the global average of $25.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Antitoxin importers in United Arab Emirates: WORLD HEALTH ORGANIZATION WAREHOUSE is the largest buyer, accounting for 40.5% ($404.0K) of this market's total imports.
• WORLD HEALTH ORGANIZATION WAREHOUSE — $404.0K (40.5% of United Arab Emirates's total)
Key Insight: United Arab Emirates's per-shipment average of $99.8K (292% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Arab Emirates is a key market for Antitoxin imports from India.
4Sudan
Sudan ranks as the fourth-largest destination for Antitoxin imports from India, with a total trade value of $969.5K across 2 shipments — representing a 7.3% share of all Antitoxin exports. The average shipment value of $484.8K is above the global average of $25.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Antitoxin importers in Sudan: SFSMN is the largest buyer, accounting for 50.1% ($485.5K) of this market's total imports.
• SFSMN — $485.5K (50.1% of Sudan's total)
Key Insight: Sudan's per-shipment average of $484.8K (1803% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sudan is a key market for Antitoxin imports from India.
5Indonesia
Indonesia ranks as the fifth-largest destination for Antitoxin imports from India, with a total trade value of $715.2K across 2 shipments — representing a 5.4% share of all Antitoxin exports. The average shipment value of $357.6K is above the global average of $25.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Antitoxin importers in Indonesia: CUST ID:AWY BACL001 is the largest buyer, accounting for 32.4% ($231.4K) of this market's total imports.
• CUST ID:AWY BACL001 — $231.4K (32.4% of Indonesia's total)
Key Insight: Indonesia's per-shipment average of $357.6K (1304% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Indonesia is a key market for Antitoxin imports from India.
People Also Ask — Antitoxin Supplier & Trade Network
Who are the top suppliers of Antitoxin from India?+
Which companies buy Antitoxin from Indian manufacturers?+
Where does Antitoxin exported from India go?+
What is the market share of the top Antitoxin supplier from India?+
What is the average shipment value for Antitoxin exports from India?+
Is Antitoxin manufactured in India and exported globally?+
Which country imports the most Antitoxin from India?+
Who are the buyers of Antitoxin in Morocco?+
How concentrated is the Antitoxin supplier market in India?+
How do I find verified buyers for Antitoxin in specific countries?+
Antitoxin Trade Network — Key Takeaways
- 1VINS BIOPRODUCTS LIMITED is India's dominant Antitoxin exporter with a 17.5% market share and $2.3M in total exports — making it the single most important sourcing entity in this market.
- 2The top 45 suppliers collectively account for 37.2% of all tracked Antitoxin exports, with a combined trade value of $13.3M.
- 3France is the largest destination market, absorbing 30.9% of India's Antitoxin exports ($4.1M). Morocco (11.4%) and United Arab Emirates (7.5%) follow.
- 4With 524 total shipments averaging $25.5K each, the Antitoxin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include CUST ID :- CMN IPDM, CUST ID:FPPGQ, WORLD HEALTH ORGANIZATION WAREHOUSE, MSF LOG-BDX SITE MERIGNAC, — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 80 countries
Network value: $13.3M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Antitoxin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Antitoxin.
- 2.Flow Mapping: 45 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 524 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 80 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
524 Verified Shipments
45 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists